New Diabetes Therapies and Diabetic Kidney Disease Progression: the Role of SGLT-2 Inhibitors

Overview of attention for article published in Current Diabetes Reports, March 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter: 3 X users

patent: 2 patents

Citations

dimensions_citation: 58 Dimensions

Readers on

mendeley: 111 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 62,803 followers.

RT @kidney_md: @rajkbasudeo @divyaa24 @akforg #APEXBrc #apexbrc Overview of SGLT2 inhibitors https://t.co/6I0HlbsLV2 https://t.co/gG7pKLB…

Reply Repost Favourite

RT @kidney_md: @rajkbasudeo @divyaa24 @akforg #APEXBrc #apexbrc Overview of SGLT2 inhibitors https://t.co/6I0HlbsLV2 https://t.co/gG7pKLB…

Reply Repost Favourite

@rajkbasudeo @divyaa24 @akforg #APEXBrc #apexbrc Acute fall in GFR Canagliflozin vs Glimeperide during first 4 weeks https://t.co/kJ4WgQ3Mew @kotharijatin @Ubkhanna https://t.co/eFF0k4mQwc

Reply Repost Favourite

@rajkbasudeo @divyaa24 @akforg #APEXBrc #apexbrc Overview of SGLT2 inhibitors https://t.co/6I0HlbsLV2 https://t.co/gG7pKLBz0T

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.